Immune Responses in Parkinson's Disease: Interplay between Central and Peripheral Immune Systems

por Su, Xiaomin, Federoff, Howard J.
Publicado 2014

Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson’s Disease

por Subramaniam, Sudhakar R., Federoff, Howard J.
Publicado 2017

Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications

por Fiandaca, Massimo S., Bankiewicz, Krystof S., Federoff, Howard J.
Publicado 2012

Single-Chain Fragment Variable Passive Immunotherapies for Neurodegenerative Diseases

por Huang, Liang, Su, Xiaomin, Federoff, Howard J.
Publicado 2013

Fetal Bovine Serum-Derived Extracellular Vesicles Persist within Vesicle-Depleted Culture Media

por Lehrich, Brandon M., Liang, Yaxuan, Khosravi, Pooya, Federoff, Howard J., Fiandaca, Massimo S.
Publicado 2018

HUMMR, a hypoxia- and HIF-1α–inducible protein, alters mitochondrial distribution and transport

por Li, Yan, Lim, Seung, Hoffman, David, Aspenstrom, Pontus, Federoff, Howard J., Rempe, David A.
Publicado 2009

Plasma microRNA markers of upper limb recovery following human stroke

por Edwardson, Matthew A., Zhong, Xiaogang, Fiandaca, Massimo S., Federoff, Howard J., Cheema, Amrita K., Dromerick, Alexander W.
Publicado 2018

Author Correction: Plasma microRNA markers of upper limb recovery following human stroke

por Edwardson, Matthew A., Zhong, Xiaogang, Fiandaca, Massimo S., Federoff, Howard J., Cheema, Amrita K., Dromerick, Alexander W.
Publicado 2020

Evaluation of an AAV2-Based Rapamycin-Regulated Glial Cell Line-Derived Neurotrophic Factor (GDNF) Expression Vector System

por Hadaczek, Piotr, Beyer, Janine, Kells, Adrian, Narrow, Wade, Bowers, William, Federoff, Howard J., Forsayeth, John, Bankiewicz, Krystof S.
Publicado 2011

Systems healthcare: a holistic paradigm for tomorrow

por Fiandaca, Massimo S., Mapstone, Mark, Connors, Elenora, Jacobson, Mireille, Monuki, Edwin S., Malik, Shaista, Macciardi, Fabio, Federoff, Howard J.
Publicado 2017

Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of...

por Janelsins, Michelle C, Mastrangelo, Michael A, Oddo, Salvatore, LaFerla, Frank M, Federoff, Howard J, Bowers, William J
Publicado 2005

Plasma metabolomic biomarkers accurately classify acute mild traumatic brain injury from controls

por Fiandaca, Massimo S., Mapstone, Mark, Mahmoodi, Amin, Gross, Thomas, Macciardi, Fabio, Cheema, Amrita K., Merchant-Borna, Kian, Bazarian, Jeffrey, Federoff, Howard J.
Publicado 2018

PGC−1α Promoter Methylation in Parkinson’s Disease

por Su, Xiaomin, Chu, Yaping, Kordower, Jeffrey H., Li, Bin, Cao, Hong, Huang, Liang, Nishida, Maki, Song, Lei, Wang, Difei, Federoff, Howard J.
Publicado 2015

Combined delivery of Nogo-A antibody, neurotrophin-3 and the NMDA-NR2d subunit establishes a functional ‘detour’ in the hemisected spinal cord

por Schnell, Lisa, Hunanyan, Arsen S, Bowers, William J, Horner, Philip J, Federoff, Howard J, Gullo, Miriam, Schwab, Martin E, Mendell, Lorne M, Arvanian, Victor L
Publicado 2011

Metabolomic biomarkers of pancreatic cancer: a meta-analysis study

por Mehta, Khyati Y., Wu, Hung-Jen, Menon, Smrithi S., Fallah, Yassi, Zhong, Xiaogang, Rizk, Nasser, Unger, Keith, Mapstone, Mark, Fiandaca, Massimo S., Federoff, Howard J., Cheema, Amrita K.
Publicado 2017

Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein

por Béraud, Dawn, Hathaway, Hannah A., Trecki, Jordan, Chasovskikh, Sergey, Johnson, Delinda A., Johnson, Jeffrey A., Federoff, Howard J., Shimoji, Mika, Mhyre, Timothy R., Maguire-Zeiss, Kathleen A.
Publicado 2012

Potential Metabolomic Linkage in Blood between Parkinson’s Disease and Traumatic Brain Injury

por Fiandaca, Massimo S., Gross, Thomas J., Johnson, Thomas M., Hu, Michele T., Evetts, Samuel, Wade-Martins, Richard, Merchant-Borna, Kian, Bazarian, Jeffrey, Cheema, Amrita K., Mapstone, Mark, Federoff, Howard J.
Publicado 2018

Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer’s Disease

por Fiandaca, Massimo S., Zhong, Xiaogang, Cheema, Amrita K., Orquiza, Michael H., Chidambaram, Swathi, Tan, Ming T., Gresenz, Carole Roan, FitzGerald, Kevin T., Nalls, Mike A., Singleton, Andrew B., Mapstone, Mark, Federoff, Howard J.
Publicado 2015

Inhibitors of Leucine Rich Repeat Kinase 2 (LRRK2) Protect Against LRRK2-Models of Parkinson’s Disease

por Lee, Byoung Dae, Shin, Joo-Ho, VanKampen, Jackalina, Petrucelli, Leonard, West, Andrew B., Ko, Han Seok, Lee, Yun, Maguire-Zeiss, Kathleen A., Bowers, William J., Federoff, Howard J., Dawson, Valina L., Dawson, Ted M.
Publicado 2010

A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease

por Macciardi, Fabio, Giulia Bacalini, Maria, Miramontes, Ricardo, Boattini, Alessio, Taccioli, Cristian, Modenini, Giorgia, Malhas, Rond, Anderlucci, Laura, Gusev, Yuriy, Gross, Thomas J., Padilla, Robert M., Fiandaca, Massimo S., Head, Elizabeth, Guffanti, Guia, Federoff, Howard J., Mapstone, Mark
Publicado 2022